Molecular and spatial differences in the tumor microenvironment of high-grade serous ovarian cancers with short versus long-term survival

OBJECTIVE: Survival of patients diagnosed with advanced-stage high-grade serous ovarian cancer (HGSOC) varies widely. Understanding the biological and molecular differences between tumors associated with short-term and long-term survival may inform prognosis and treatment. METHODS: Omental tumor samples were collected from 15 short-term survivors (STS; <12 months) and 15 long-term survivors (LTS; ≥ 120 months) with stage III-IV HGSOC who underwent primary debulking surgery followed by platinum-based chemotherapy. Bulk tumor sections were analyzed using whole-genome RNA sequencing. Corresponding H&E-stained whole-slide images were processed using machine learning-based cell segmentation to identify cell phenotypes. Computational image analysis was used to extract morphometric features. The integrated transcriptomic and image-derived data were used to quantify proportions of cancer cells, fibroblasts, and immune cells, and to identify differences in nuclear texture, cancer cell spatial organization, and collagen architecture. RESULTSS: STS was associated with higher fibroblast content (48.6% vs 33.5%, p < 0.05), lower cancer cell content (48.0% vs 64.3%, p < 0.05), and a lower tumor-fibroblast proportion (0.9 vs 1.8, p < 0.05) than LTS. Computational image analyses identified significant differences in nuclear texture, cancer cell spatial organization, and collagen architecture. STS correlated with upregulation of fibroblast-associated genes (ITGAV, p < 0.05; INHBA, p < 0.0001) and epithelial-mesenchymal transition markers (ZEB1, p < 0.001; CALD1, p < 0.001), while LTS was enriched for immune signaling pathways. CONCLUSIONS: Omental metastases from STS and LTS patients have distinct molecular and spatial profiles. The enrichment of fibroblast-associated gene signatures in STS and immunoreactive pathways in LTS underscores a divergent tumor microenvironment with potential clinical relevance.

Authors

Institutions

Publication Details

Journal
Gynecologic Oncology
Published
2026-05-23
DOI
https://doi.org/10.1016/j.ygyno.2026.05.017
Primary Topic
Ovarian cancer diagnosis and treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Molecular and spatial differences in the tumor microenvironment of high-grade serous ovarian cancers with short versus long-term survival

Arkadiusz Gertych, Ann E. Walts, Sandra Oršulić, Natalia Zurek et al.
Gynecologic Oncology
Ovarian cancer diagnosis and treatment
article

Molecular and spatial differences in the tumor microenvironment of high-grade serous ovarian cancers with short versus long-term survival

Arkadiusz Gertych, Ann E. Walts, Sandra Oršulić, Natalia Zurek, Beth Y. Karlan, Barbie Taylor-Harding, Alexandra H. Smick
article en

Abstract

OBJECTIVE: Survival of patients diagnosed with advanced-stage high-grade serous ovarian cancer (HGSOC) varies widely. Understanding the biological and molecular differences between tumors associated with short-term and long-term survival may inform prognosis and treatment. METHODS: Omental tumor samples were collected from 15 short-term survivors (STS; <12 months) and 15 long-term survivors (LTS; ≥ 120 months) with stage III-IV HGSOC who underwent primary debulking surgery followed by platinum-based chemotherapy. Bulk tumor sections were analyzed using whole-genome RNA sequencing. Corresponding H&E-stained whole-slide images were processed using machine learning-based cell segmentation to identify cell phenotypes. Computational image analysis was used to extract morphometric features. The integrated transcriptomic and image-derived data were used to quantify proportions of cancer cells, fibroblasts, and immune cells, and to identify differences in nuclear texture, cancer cell spatial organization, and collagen architecture. RESULTSS: STS was associated with higher fibroblast content (48.6% vs 33.5%, p < 0.05), lower cancer cell content (48.0% vs 64.3%, p < 0.05), and a lower tumor-fibroblast proportion (0.9 vs 1.8, p < 0.05) than LTS. Computational image analyses identified significant differences in nuclear texture, cancer cell spatial organization, and collagen architecture. STS correlated with upregulation of fibroblast-associated genes (ITGAV, p < 0.05; INHBA, p < 0.0001) and epithelial-mesenchymal transition markers (ZEB1, p < 0.001; CALD1, p < 0.001), while LTS was enriched for immune signaling pathways. CONCLUSIONS: Omental metastases from STS and LTS patients have distinct molecular and spatial profiles. The enrichment of fibroblast-associated gene signatures in STS and immunoreactive pathways in LTS underscores a divergent tumor microenvironment with potential clinical relevance.

Gynecologic OncologyVol. 210
Cedars-Sinai Medical Center (US), University of California, Los Angeles (US), VA Greater Los Angeles Healthcare System (US)
U.S. Department of Defense, U.S. Department of Veterans Affairs, National Cancer Institute, David Geffen School of Medicine, University of California, Los Angeles
Zero hunger
Openalex Percentile: Top 4%
Ovarian cancer diagnosis and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.